Inventor · disambiguated record
Mamta Kalra
Also filed as: KALRA MAMTA
5 granted patents·17 pending applications·4 citations·filing 2019–2025
68Inventor score
Files withIMMATICS US INC22
Top patents by PatentIndex Score
22 records- 0182US11851673B2WPRE mutant constructs, compositions, and methods thereofIMMATICS US INC·Filed 2021·Granted Dec 26, 2023·1 cites·20 claims
- 0278US12123013B2WPRE mutant constructs, compositions, and methods thereofIMMATICS US INC·Filed 2023·Granted Oct 22, 2024·0 cites·19 claims
- 0376US2025075230A1Wpre mutant constructs, compositions, and methods thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0474US11464800B2Methods for manufacturing T cellsIMMATICS US INC·Filed 2019·Granted Oct 11, 2022·3 cites·20 claims
- 0572US2025034588A1Methods of assessing potency of viral vectorsIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0668US2025051418A1Viral vectors and use thereof in adoptive cellular therapyIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0765US2025019655A1Cd28 t cell cultures, compositions, and methods of using thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0863US2025002855A1Methods for expanding t cells for the treatment of cancer and related malignanciesIMMATICS US INC·Filed 2024·Application pending·0 cites
- 0960US2023355678A1Methods for improving t cell efficacyIMMATICS US INC·Filed 2023·Application pending·0 cites
- 1059US11975025B2Viral vectors and use thereof in adoptive cellular therapyIMMATICS US INC·Filed 2020·Granted May 7, 2024·0 cites·16 claims
- 1158US12234473B2CD8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2021·Granted Feb 25, 2025·0 cites·12 claims
- 1258US2025134931A1Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2024·Application pending·0 cites
- 1357US2023089392A1Monocyte depletion of t cells populations for t-cell therapyIMMATICS US INC·Filed 2022·Application pending·0 cites
- 1457US2023348548A1Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 1555US2024066127A1Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 1654US2023348561A1Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereofIMMATICS US INC·Filed 2023·Application pending·0 cites
- 1752US2021030803A1Methods for manufacturing t cellsIMMATICS US INC·Filed 2020·Application pending·0 cites
- 1852US2022280564A1Methods for expanding t cells for the treatment of cancer and related malignanciesIMMATICS US INC·Filed 2021·Application pending·0 cites
- 1951US2019216852A1Methods of assessing potency of viral vectorsIMMATICS US INC·Filed 2019·Application pending·0 cites
- 2050US2022056411A1Methods for isolating cd8+ selected t cellsIMMATICS US INC·Filed 2021·Application pending·0 cites
- 2143US2020297768A1Cd28 t cell cultures, compositions, and methods of using thereofIMMATICS US INC·Filed 2020·Application pending·0 cites
- 2239US2025146019A1Cd8 polypeptides, compositions, and methods of using thereofIMMATICS US INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mamta Kalra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →